Skip to content

Study of China ‘insect’ vaccine for COVID-19 set to begin

August 24, 2020

China’s National Medical Products Administration has signed off on a clinical trial evaluating a COVID-19 vaccine made with proteins grown in insect cells, an approach that could speed up large-scale production.

The trial will be conducted by the West China Hospital of Sichuan University in Chengdu.

The vaccine prevented infection with no obvious side effects in a non-human primate study.

Chinese authorities also announced that they have been testing a potential coronavirus vaccine in a select group of workers, primarily border officials and health workers, since July, the first confirmation by any country of such activity outside of clinical trials.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: